Engineering Processing Properties of Acetaminophen by Cosolvent Screening - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Engineering Processing Properties of Acetaminophen by Cosolvent Screening
The authors used common solvents to develop an initial solvent-screening method for laboratory-scale research to determine the solubility, polymorphism, and crystal properties of various active ingredients.


Pharmaceutical Technology
Volume 34, Issue 8, pp. 61-68

Conclusion

Cosolvent screening is a useful and beneficial method for finding ideal cosolvent systems to create the desirable processing properties of acetaminophen crystals because cosolvent systems offered a wide range of choices in solubility, theoretical yield, crystal habit, aspect ratio, and crystallinity. Although small crystal sizes are advantageous for decreasing the force exerted on the roll-bearing blocks for roll compaction and for enhancing the dissolution rate because they lower εn and raise S, respectively (see Table I), small crystal sizes can lengthen the drying rate, the filtration rate, the mixing rate, and the growth rate of granules in the nuclear growth region because of the decreases in R c (which resulted from strong capillary force), D p, k 2, and X a, respectively (see Table I). Crystals with an aspect ratio higher than 3 have needle shapes that are easily broken into pieces of smaller crystal and fines. Therefore, systems produced relatively large crystal sizes, aspect ratios of ~1, and high theoretical yield such as that of the ethyl acetate and acetonitrile system. The authors will carry out similar investigations in the near future for the antisolvent systems represented by the green boxes in Table II and the scale-up effect on the crystal-size distribution.

Acknowledgments

This work was supported by a grant from the national Science Council of Taiwan, ROC (NSC 97-2113-M-008-006). Suggestions about DSC from Jui-Mei Huang, at Precision Instrument Center in National Central University are gratefully acknowledged.

Tu Lee* is an associate professor, and Gen Da Chang is a graduate student at the Department of Chemical and Materials Engineering, National Central University, 300 Jhong-Da Rd., Jhong-Li City 320, Taiwan, ROC, tel. +886 3 422 7151 ext. 34204, fax +886 3 425 2296,
.

*To whom all correspondence should be addressed.

Submitted: Aug. 13, 2009. Accepted: Nov. 20, 2009.

References

1. A.H. Goldberg, M. Gibaldi, and J.L. Kanig, J. Pharm. Sci. 55 (5), 482–487 (1966).

2. M.D. Rawlins, D.B. Henderson, and A.R. Hijab, Eur. J. Clin. Pharmacol. 11 (4), 283–286 (1977).

3. J.B. Sotiropoulus, T. Deutsch, and F.M. Plakogiannis, J. Pharm. Sci. 70 (4), 422–425 (1980).

4. B. Ameer et al., J. Pharm. Sci. 72 (8), 955–958 (1983).

5. M.M. Parmar et al., Cryst. Growth Des. 7 (9), 1635–1642 (2007).

6. S.L. Morissette et al., Adv. Drug Deliv. Rev. 56 (3), 275–300 (2004).

7. T. Lee, C.S. Kuo, and Y.H. Chen, Pharm. Technol. 30 (10), 72–92 (2006).

8. T. Lee, Y.H. Chen, and C.W. Zhang, Pharm. Technol. 31 (6), 72–87 (2007).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here